Spring Bank Pharmaceuticals Stops Trial Of Hepatitis B Drug Following Patient Death

January 30, 2020

Reuters (1/29, Roy) reports Spring Bank Pharmaceuticals announced “it would end the development of an experimental drug to treat chronic hepatitis B virus, following the death of a patient in a mid-stage trial.” The company said it ended the phase 2b tria...